Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06252948 · ClinicalTrials.gov registry record
Gut Microbiome Studies in Patients With POEMS Syndrome and Other Plasma Cell Disorders
A clinical trial of Plasma Cell Disorders, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 240
- Enrollment target
- 1
- Study location
NCT06252948 is a study of Plasma Cell Disorders that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 240 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06252948, a study of Plasma Cell Disorders, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
A Study to Evaluate Gut Microbiome with POEMS Syndrome and Other Plasma Cell Disorders
Conditions Studied
Interventions
- OTHER Non-interventional study (observational)
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2021-12-29 |
| Est. Completion | 2028-12-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06252948
The ClinicalTrials.gov registry entry for NCT06252948 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Plasma Cell Disorders appearing as the primary indexed condition, and to 1 intervention - of which Non-interventional study (observational) is the first listed.
NCT06252948 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT06252948 about?
NCT06252948 is a clinical study titled "Gut Microbiome Studies in Patients With POEMS Syndrome and Other Plasma Cell Disorders". A Study to Evaluate Gut Microbiome with POEMS Syndrome and Other Plasma Cell Disorders
What is the current status of trial NCT06252948?
This trial is currently recruiting. The enrollment target is 240 participants. The study started on 2021-12-29. Estimated completion is 2028-12-29.
What conditions does trial NCT06252948 study?
This clinical trial studies the following conditions: Plasma Cell Disorders.
What interventions are being tested in trial NCT06252948?
The interventions under investigation include: Non-interventional study (observational) (OTHER).
Who is sponsoring clinical trial NCT06252948?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06252948 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Plasma Cell Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.